The Technical Analyst
Biomm S.A. [BIOM3.SA]
Exchange: EURONEXT Sector: Healthcare Industry: Biotechnology
Biomm S.A. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.63% BRL15.70
America/New_York / 17 mai 2024 @ 16:06
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 991.40 mill |
| EPS: | -0.980 |
| P/E: | -16.02 |
| Earnings Date: | Mar 31, 2023 |
| SharesOutstanding: | 126.84 mill |
| Avg Daily Volume: | 0.139 mill |
| RATING 2024-05-17 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -16.02 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -16.02 | industry: PE -7.48 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
BRL 14.41 - 16.99 ( +/- 8.21%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
Forecast
1: 15:16 - BRL15.75
Forecast 2: 16:00 - BRL15.70
Forecast 3: 16:00 - BRL15.70
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | BRL15.70 (-1.63% ) |
| Volume | 0.0287 mill |
| Avg. Vol. | 0.139 mill |
| % of Avg. Vol | 20.61 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BIOM3.SA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BIOM3.SA
Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; CONFORT CARE, a moisturizing foot cream; GLARGILIN, a glargine insulin; and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in São Paulo, Brazil.